This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Goodnough, L. T. Articles by Martin, J. W. Search for Related Content PubMed PubMed Citation Articles by Goodnough, L. T. Articles by Martin, J. W. Social Bookmarking                         What's this?

Blood Transfusion and Blood Conservation: Cost and Utilization Issues

Departments of Medicine, Pathology, Washington University school of Medicine

Mathew S. Bodner, M.D.

Department of Anesthesiology, Washington University School of Medicine

Jeffery W. Martin, M.D.

The Missouri Bone and Joint Clinic, St. Louis, Missouri

Approximately 12 million red blood cell units are transfused to nearly 4 million patients annually in the United States (1). The conservation of blood has historically arisen from awareness that the inventory of this resource is limited (2), as well as the knowledge that blood transfusion carries a risk (3). Estimates of current blood transfusion risks (4- 12) , and the costs of transfusion complications (13—17), are summa rized in Table 1. In addition, emphasis on the costs of health care has raised issues related to the costs of blood transfusion (18, 19). Finally, recent guidelines have emphasized that in the elective transfusion set ting, no blood transfusion is a desirable outcome (20, 21). Furthermore, these guidelines along with consen sus conference recommendations (22) have emphasized that if blood is to be transfused, autologous (the pa tient's own) blood is preferable to allogeneic (from an anonymous, volunteer donor) blood. Thus, the costs of blood conservation, for which an increasing array of technologic procedures and products have become available (Table 2), have also become an issue (23). The purpose of this review is to provide an overview of emerging data on the cost-effectiveness of blood and blood conservation interventions in order to help iden tify areas important for future investigation.

American Journal of Medical Quality, Vol. 9, No. 4, 172-183 (1994)
DOI: 10.1177/0885713X9400900408


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?